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Background: The response to COVID-19 catalyzed the adoption and integration of digital health tools into
the health care delivery model for musculoskeletal patients. The change, suspension, or relaxation of
Medicare and federal guidelines enabled the rapid implementation of these technologies. The expansion
of payment models for virtual care facilitated its rapid adoption. The authors aim to provide several
examples of digital health solutions utilized to manage orthopedic patients during the pandemic and
discuss what features of these technologies are likely to continue to provide value to patients and cli-
nicians following its resolution.
Conclusion: The widespread adoption of new technologies enabling providers to care for patients
remotely has the potential to permanently change the expectations of all stakeholders about the way
care is provided in orthopedics. The new era of Digital Orthopaedics will see a gradual and nondisruptive
integration of technologies that support the patient’s journey through the successful management of
their musculoskeletal disease.
© 2020 Published by Elsevier Inc.Background
The COVID-19 pandemic is placing a massive strain on the ability
to deliver care to patients with musculoskeletal complaints. In the
worldof hipandkneearthroplasty,which generallycares foranolder
populationwith a number of comorbidities, patients are being asked
to delay interventions until hospitals are safe for elective surgery.closed potential or pertinent
ment, either direct or indirect,
n the biomedical field which
rest with this work. For full
j.arth.2020.04.048.
ose of the authors and do notCare delivery models based on the in-person visit are therefore
not able to meet patient needs in the context of “stay-at-home
measures” and “social distancing”. Conversely, digital health tools
have been particularly useful in the response to COVID-19 because
they enable care to be delivered at a distance. It is important to note
therefore that the class of tools and applications generally termed
“Digital Health” may change the paradigm of how we deliver carenecessarily reflect the official policy or position of the Department of the Navy,
Department of the Army, Department of Defense, nor the US Government. Nothing
in the presentation implies any Federal/Department of Defense/Department of the
Navy endorsement.
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exercise for knee strengthening is proposed by a therapist or an
avatar does not change the nature of the exercise itself. This is an
important distinction as these technologies are designed to enable
and simplify the delivery of care, not to change the actual treat-
ments we provide patients. They are each designed as solving a
pain point somewhere along the analog patient journey. Their
business models depend on it. Digital health tools can track and
backfill surgery cancellations, free doctors from taking notes during
virtual visits, identify patients at risk for treatment failure, triage
patient questions to decompress human phone banks, refresh
surgical skills and procedures virtually, track and manage patient
recovery at home, and print equipment that is not otherwise
available among a litany of functions that focus on enabling better
care delivery. These technologies aim to support patients along
their health care journey and help, and not replace, providers.
Contrary to the claims by most startups seeking funding in Sili-
con Valley, digital adoption does not have to be disruptive. New
technologies require new skill sets and, unfortunately, many
perceive their adoption as threatening their livelihood or their
inherent value to the system. Although such a point of viewmay be
common, it is wide of the mark. In a recent article in Harvard
Business Review [1], the authors made several salient points
regarding the topic of the perceived disruptive nature of digitali-
zation. They point out that the adoption of new technology does not
require thewholesale disruption of the current value proposition of
a practice or hospital, but rather the implementation of digital tools
enables the same institution to better serve its patients; they
emphasize that digital will not replace physical, but rather augment
it. They underscore that digitalization does not require a painful
overhaul of legacy systems but rather a focus on incremental
bridging fromone setof technologies to another.Weacknowledge at
the outset that the wholesale transition to electronic health records
(EHRs) was painful and expensive. Many physicians resent the
amount of data entry required. On the upside, the EHR adoption in
the United States is around 95% and the digital infrastructure that
supports it does allow for an ecosystem of products to connect to
each other through middleware applications that sit as in-
termediaries between the EHR andmore useful applications. During
the pandemic, we have seen how digital solutions can improve
patient care by complementing standard analog care models.
Critical to this success was the fact that the federal government
and the Center for Medicaid and Medicaid Services quickly imple-
mented new payment models supporting the use of virtual care
platforms. Medicare adopted equivalency payment models for tele
and in-person care, voided the need for the existence of a prior
patient-physician relationship to pay claims for telehealth visits,
state medical licensure requirements were waived, and Health In-
surance Portability and Accountability Act rules were relaxed
allowing televisits to be performed via regular phones and
commonly used social media applications. While these restrictions
will be relaxed only for the duration of the pandemic, it is likely that
many will not be fully reinstated. As a result, Telehealth, Digital
Health and mHealth (mobile health) companies have all seen a
marked uptick in adoption of their services as health care providers
seek to use digital tools to care for patients sheltering at home.
The goal of this communication is therefore to describe technol-
ogies that have been particularly helpful in the orthopedic response
to COVID-19 and that the authors believe will remain relevant to the
musculoskeletal community even after the end of the pandemic.
Telemedicine Platforms
Telemedicine platforms are the backbone of virtual care and
quickly became an invaluable resource for health care systemsresponding to the COVID-19 pandemic. They enabled not onlymore
efficient triage of the increasing volume of possible COVID-19 pa-
tients but did so while importantly protecting our health care pro-
viders and complying with “social distancing.” In addition,
telemedicine served as a tool for specialty providers to help offload
primary care providers, urgent care clinics, and emergency de-
partments of other acute and chronic issues that could be managed
without their involvement. This allowed primary care and emer-
gency room providers to focus on the higher acuity COVID-19 pa-
tients aswell as preventovercrowdingof their facilities. The realities
that enabled the ease with which the transition to virtual care took
place in the United States are multifactorial but can be broadly
categorized into three buckets. First, the infrastructure for tele-
medicine was readily available in the United States as digitized
clinical records could be accessed remotely through secure portals.
Second, new state and federal regulatory guidelines removed the
last enduring barriers to the widespread adoption of telehealth
platforms by changing the payment models. Third, the venture
capital invested into telemedicine startups over the past decade has
enabled a ready, able, and vibrant ecosystem to exist. As reported by
Mobile Health News, the amount of capital invested in digital health
in the first half of 2019 alonewas over $1.5 billion and cappedmany
years of progressively increasing funding for the sector.
Virtual and Digital Scribes
COVID-19 led to the nearly overnight end of clinic visits and a
rapid rise in virtual care with many practices going from 1%-2% of
all visits being online to nearly 100%. In-person scribe services were
already common in clinics where the administrative burden of
documentation was perceived to be untenable. Many practices had
to quickly pivot from the in-person scribe model to utilizing virtual
scribes on telehealth platforms. These virtual scribes, like their in-
person counterparts, can document visits in the EHR and free the
provider to engagewith the patient on the online portal. The virtual
scribes log into the visit and have access to everything the clinician
sees and hears. Digital scribes are joining the party as well. Virtual
digital scribes are software programs that take advantage of the
rapid advances in the branch of artificial intelligence (AI) devoted to
voice recognition. Coupled to complex ontologies trained on hun-
dreds of thousands of medical articles, these algorithms can listen
to a natural conversation between the patient and the clinician and
create the equivalent of a clinical note, place it in the chart, and
even provide an evaluation of the note for billing. Simpler programs
can take and transcribe a dictation.
As virtual digital scribes become further integrated into tele-
health platforms, they will be able to support clinicians working
from home seeing patients without their support staff. Although
randomized control trials have shown that access to scribes can
decrease charting time and increase physician satisfaction [2], little
is known about the impact of digital scribes on patient or
decreasing physician burnout. Their increased adoption in busy
clinics and Emergency Departments has, however, been noted by
companies in the space and while still in their formative years, the
potential of these companies should not be underestimated.
Chatbots
Chatbots can triage calls freeing staff to focus on more complex
problems. What makes chatbots different is that they use AI to not
only understand the question being posed in “natural” language,
but also to select the corresponding answer from a selection of
options. For example, if a patient asks about a “headache”, “pain
between the ears”, or “throbbing in the head”, the chatbot un-
derstands all three to be referring to a headache. It can then ask
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mend an appointment, or triage the patient to a provider. These
tools are excellent for screening patients for symptoms, checking
on medication adherence, or to follow up on symptoms, and can be
based either on text, voice, or email [3].
At the earliest signs of the current pandemic, the World Health
Organization quickly set up a chatbot screener for COVID-19
symptoms. Similar tools were quickly implemented in Seattle to
help local government track the spread of the virus. Jefferson
Health’s telemedicine system successfully used chatbots to triage
patients without the need for in-person care. The University of
California San Francisco designed and deployed an employee
screening chatbot that decreased hospital entrance times from
30 minutes to less than one minute. There are many companies
currently offering chatbot services to manage everything from
patient scheduling to collecting patient-reported outcomes. The
success of chatbots during the COVID-19 response and the fact that
many are now active and integrated into numerous health care
system’s informatics infrastructure, suggests that their use will
expand following the resolution of the pandemic.
Virtual Physical Therapy and Telerehabilitation
The COVID-19 pandemic has resulted in the need for “social
distancing,” avoiding in-person contact and crowded, enclosed
places. The traditional care model for recovery after hip and knee
arthroplasty involves intensive in-home physical therapy (PT) and/
or in-person outpatient therapy. The need to maintain “social
distancing” coupled with the previously mentioned payment re-
forms have led to a surge in the availability of both telehealth PT
options from PT providers as well as virtual PT delivered by avatars.
For many patients, both of these options provide customized PT in
the comfort of a patient’s home at a lower cost, thus establishing a
more adaptable and equally effective PT pathway than traditional
in-person PT.
Bettger et al performed a prospective, randomized trial of an
avatar-based virtual PT program for patients after unilateral TKA
and compared clinical and economic outcomes for their patients.
They found that compared with traditional in-home or clinic-based
PT, avatar-based virtual PT significantly decreased 3-month asso-
ciated health-related costs while providing equivalent clinical
outcomes. They stressed the importance of appropriate clinical
oversight of any truly virtual PT program to ensure patients prog-
ress appropriately. This oversight can be provided by a physical
therapist, physician, or physician extender [4].
Fisher et al described a physical therapistebased telehealth
navigation platform that included not only telehealth visits with a
live physical therapist, but also care navigation with a nurse prac-
titioner that was available to perform real-time assessments in the
postoperative period after joint arthroplasty. They noted a signifi-
cant cost savings associated with this telehealth care navigation
platform compared with their standard pathway, the avoidance of
in-person evaluations for minor postoperative concerns, and an
absence of readmissions in their telerehabilitation group [5].
Data Science
The COVID-19 pandemic has elevated the importance of data,
data science, and data-driven decision-making to the forefront of
medicine and national policy as leaders have struggled to make
important life and death decisions because of a lack of high-quality
data to guide them [6]. For those with expertise in data science, the
COVID-19 pandemic has been nothing short of humbling. Three
anecdotes that bring important data-related learnings to light are
listed in the following.First, COVID-19 has shown that data quality is of supreme
importance in the context of predictive analytics. When there is a
paucity of reliable data, no amount of technology will provide the
insights needed for good decision-making. For example, no piece
of data would have been more important or valuable in this
pandemic than the accurate, up-to-date number of COVID-19
cases in the country, ideally broken down by geographic region.
Yet, an accurate count of COVID-19 cases has not been available
making forecasting the spread of the pandemic particularly diffi-
cult [7]. The lack of this seemingly rudimentary data point (the
number of new cases over time) further made machine learning
and AI, both much touted technologies of our day, powerless. This
evolving story drives home the point that data is king, and that
getting accurate, unbiased data in real time is paramount and that
in the absence of accurate and sufficient data predictive models
are, at best, an educated guess.
Second, “flattening the curve” is a text-book example of how a
data-driven approach from epidemiology can be successfully
implemented and translated into effective policies that not only
change behavior but, when heeded, can save thousands of lives.
Flattening the curve means spreading out new cases over time so
that the health system is not overwhelmed, and the affected pop-
ulation buys time to ramp up testing and develop vaccines and
treatments. During that window, the system can provide more and
better data to optimize the models and inform decisions to fight
and manage the pandemic [8]. The elegance of the phrase, “flat-
tening the curve” is difficult to overstate. It has proven to be a life-
saving concept that was born in data and then successfully pack-
aged into a simple phrase and infographic that concisely explained
what the problem was to decision makers and the general public
alike. It lent credence and context to the phrases that explained
what to do about the problem (e.g., “social distancing” and “shelter
in place”) and their impact. The story of this data-derived insight
turned public-health meme is still unfolding but may truly go down
as one of the great public health triumphs of our day. One moral of
the story is the importance of taking our data-derived insights
across the “finish line”. Data, technology, and a good analysis alone
do not go far enough: we must make the data do something by
translating insights into effective policies that induce behavior
change if we are to achieve the desired outcome. This will be true as
we apply data science to orthopedics in the future as well.
Third, there are faint glimmers of the potential impact of ma-
chine learning on basic science in the efforts to find treatments and
a vaccine for COVID-19. In general, machine learningebased ap-
proaches are helping scientists to target their efforts to those areas
most likely to meet with success as opposed to squandering time
on experiments that are less likely to be fruitful. For example,
machine learning has helped scientists predict chemical properties
of drugs and proteins [9], predict vaccine immunogenicity [10],
identify promising drug targets [11], and even identify existing
drugs that have the potential to be repurposed for use against other
pathogens [12]. It remains to be seen if these advancements will be
successfully applied to the discovery of treatments and a vaccine for
SARS-CoV-2, the virus that causes COVID-19. The exciting potential
of machine learning is perhaps best exemplified by AlphaFold, a
machine learningebased system that has demonstrated a remark-
able ability to predict the 3D structure of proteins based solely on
genetic sequence [13]. Understanding how these proteins “fold”
allows scientists to design drugs that recognize and target those
unique antigens. The AlphaFold group has already released the
predicted structures of several understudied proteins associated
with SARS-CoV-2 in hopes that these structural predictions will
contribute to the scientific community’s understanding of how the
virus functions and serve as a starting point for future experimental
work aimed at developing therapeutics [14].
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Smartwatches and fitness trackers are receiving a lot of atten-
tion in the current COVID-19 pandemic as a consumer-level tech-
nology that aids early diagnosis of viral infections. Sensors have
been used to track fluctuations in heart rate during sleep and to
provide population-level data to determine if measures to contain
the novel coronavirus pandemic were effective. In the height of the
COVID-19 outbreak in Shanghai, China, and Veneto, Italy, wearable
sensors were utilized to monitor COVID-19epositive patients at
home to free up scarce hospital resources.
Wearable sensor devices (WSDs) may play a significant role in
the emerging age of Digital Orthopaedics. WSDs typically include
accelerometer, gyroscope, and global positioning sensors that can
track position, movement, acceleration and vital signs such as
temperature and heart rate. WSDs have potential to promote a
healthy lifestyle and improve patient engagement. Furthermore,
they can provide remote postoperative monitoring, help predict
postoperative outcomes, collect patient-reported outcome mea-
sures, facilitate gait and motion analysis, and inform returneto-
sports decisions. In one study, a 1000-step daily goal for ambulation
in the early postoperative period was associated with lower prob-
ability of prolonged length of stay after major surgery [15].
Smartwatches and fitness trackers increase patient involvement
in their care by providing real-time feedback. This has been shown
to be effective in obesity/metabolic syndrome management using
telemonitoring-supported exercise training with fitness trackers
[16]. Innovative tracking devices are available that can be worn
around operated or diseased joints to enable continuous moni-
toring of activity datadincluding range of motion, ambulation,
exercise compliance, and wound-site temperature trends. These
noninvasive connected trackers enable the surgeon to remotely
evaluate real-time data on a patient’s postoperative progress.
Real-time data collection using smartwatches as ecological
momentary assessment tools have been used in elderly patients
with arthritis to monitor their patient-reported outcomes, pain
levels, and postoperative symptoms [17]. In addition, real-time
objective physical activity data obtained from WSDs is a more
objective measurement than self-reported data for physical activ-
ity, which is subject to significant bias. Smartwatches are highly
portable and can be leveraged as an excellent medium for contin-
uous data collection.
Sensors in smartwatches can be used to extract the three main
parameters of gait: step length, swing time, and stance time [18].
This quantitative gait analysis has important implications in or-
thopedic practice for the diagnosis of a variety of musculoskeletal
issues such as concussion/collision impact and motion analysis in
sporting activities such as pitching a baseball and detecting dif-
ferences in motion that predispose patients for graft rupture
following ACL reconstruction [19]. Such data can be utilized for
making safe return-to-sports decisions. While data collection and
in particular the ability to accurately predict outcomes is still in its
infancy, it is clear that, as in COVID-19 response, there are many
opportunities to use consumer-grade sensors in orthopedic care.
Surgical Scheduling Applications
Surgical scheduling platforms simplify the complexity of
canceling and rebooking procedures. As the “curves begin to
flatten” and surgeons are given the green light to proceed with
elective surgeries, they may be overwhelmed by the task of
rescheduling these procedures. This daunting task may be difficult
to tackle with a notebook full of names, an EHR calendar not
designed for this purpose, fewer staff due to COVID-19erelated
requirements or staff reductions, concerned patients, and thecomplexity of obtaining authorizations. Some surgeons may use
the current crisis as an opportunity to implement surgery sched-
uling platforms to streamline the rescheduling process and
modernize their practice with tools that can connect multiple
hospitals, implant representatives, preoperative screening clinics,
and third-party payers through a single platform that can also
provide analytics such as utilization metrics, backlog analysis, and
cancellation mitigation tools.
All interested parties are connected to the same scheduling-
based platform and the platform can connect to nearly all EHRs,
thanks to the wide and government required implementation of
Fast HealthCare Interoperability Resource standards to assist with
data sharing between EHRs and patients or providers. Some of
these platforms can assist in rescheduling by using AI algorithms to
identify which patients are available to fill a cancellation or triage
patients by level of care to surface the most urgent. All key players
are kept informed in real time of the schedule, most notably the
patient. The goal is to keep patients engaged in the process through
direct communication while minimizing the work burden placed
on the surgeon and their support staff.
Integration can be accomplished in as little as a few days to a few
weeks depending on the complexity of the EHR integration.
Implementation and staff education can be performed and scaled
remotely. When surgeons are able to resume elective surgeries, a
scheduling-based platform may be invaluable to practices trying to
reboot their surgical workflow.
Virtual and Augmented Reality
Virtual reality (VR) is a rapidly growing technology with po-
tential applications across the episode of care for hip and knee
arthroplasty. VR provides users with immersive, interactive expe-
riences in computer-generated environments through the use of a
headset and bodymotion sensors and typically, hand controllers, in
the current generation of commercially available platforms. VR and
AR can deliver sophisticated simulations and immersive environ-
ments for remote PT and surgical training. VR has shown benefits in
resident training in multiple orthopedic subspecialties. In a recent
study, Logishetty et al. demonstrated several benefits of VR for
surgical resident training for direct anterior approach total hip
arthroplasty on cadaveric specimens. Trainees exposed to VR
training demonstrated less need for guidance or intervention, more
accurate component orientation, and were faster surgeons than the
non-VR group [20]. A follow-up study by the same group demon-
strated reduction of surgical errors and improvement in efficiency
of movement in the operating room compared with a baseline
assessment after only 4-5 hours of VR training [21]. The latest
versions of these platforms allow collaborative modes, where sur-
gical teams can practice procedures together online without
physically being in the same location. With elective orthopedic
surgical procedures on hold during the COVID-19 pandemic, VR
may provide trainees, surgeons, and even surgical assistants an
avenue to learn and maintain proficient surgical skills, all at an
acceptable social distance.
VRmay also be utilized for remote delivery of PT in patients with
hip and knee arthritis, as well as for perioperative PT. These plat-
forms enable surgeons and physical therapists to remotely pre-
scribe and monitor patient-specific programs for rehab that can be
performed in the comfort of the patient’s home. A systematic re-
view and meta-analysis demonstrated no difference between
traditional PT and VR PT for multiple orthopedic diagnoses in terms
of function and pain [22]. Similarly, an RCT focused on the use of VR
PT after TKA demonstrated noninferiority of VR PT to traditional PT
in terms of pain, strength, and range of motion [23]. Although the
cost effectiveness of VR-based PT compared with traditional in-
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role in providing hip and knee arthroplasty patients PT remotely
during and after the COVID-19 pandemic.
Patient Engagement Platforms
Patient engagement platforms (PEPs) provide both patients and
physicians a means to interact and to facilitate longitudinal care.
The utility of these software applications is in channeling and
engaging a patient’s skills, desires, and knowledge to promote
positive health outcomes [24].
Patient engagement increases a patient’s willingness to partic-
ipate in care and is associated with improved patient interactions,
decreased cost, emergency visits, and hospitalization [24e26]. PEPs
have been utilized to facilitate care in various aspects of medicine,
including smoking cessation and diabetesmanagement [27,28]. The
potential for PEPs in orthopedics to expand during and after the
current pandemic is high. Patients whose elective surgeries were
postponed are likely to experience an extended period of nonop-
erative management. PEPs can provide educational resources and
targeting at-home therapeutic alternatives proactively updating
patients regarding changes in clinic services, surgical schedules, or
COVID-19erelated policies. PEPs have been shown to provide a
meaningful connection between the patients and the provider’s
team [29,30], have demonstrated utility in collecting patient-
reported outcome measures, and save time for providers during
telemedicine encounters [31,32].
PEPs provide a convenient modality for rapid wound assess-
ment through image sharing and expedite the modification of
treatment plans for concerning wounds [29,30].
With the onset of the COVID-19 crisis, practices with PEPs
already deployed were able to use them to quickly and efficiently
deploy alternate treatment pathways for patients whose surgery
was canceled or pending. Other systems enrolled the patients
retroactively and used the platforms to rapidly share information
and answer questions to patients stranded at home.
3D-Printing Technologies
As the COVID-19 pandemic spread across the United States, it
became evident that areas affected by an outbreak of coronavirus
would stress the supply chains for many devices and tools required
for a functioning health care system. Government regulators
endorsed strategies for conservation of limited resources and the
FDA relaxed import restrictions to allow equipment not approved
by the National Institute for Occupational Safety and Health to be
used in health care settings [33].
Across the globe, engineers and hobbyists with access to addi-
tive manufacturing platforms (“3D printers”) rushed forward with
innovative solutions to help mitigate some of the equipment
shortfalls. Designs for the manufacture of masks, face shields, and
ventilator splitters were made available online through the Na-
tional Institute of Health 3D Print Exchange [34]. Many community
projects worked to provide personal protective equipment to
frontline health care and other essential workers without adequate
access to personal protective equipment. These grassroots volun-
teer campaigns organized to manufacture masks and face shields in
their homes or businesses and distributed themwidely at no cost in
settings ranging from grocery stores to large hospital systems [35].
Additive manufacturing has also been utilized to produce other
complex components during this crisis. When the original supplier
for a connector valve for a ventilator in use at an Italian hospital was
unable to meet the sudden increase in demand, a local engineering
firm was able to produce 100 of the components utilizing 3D
printers within 24 hours [36]. A multidisciplinary team is testing anovel design for a ventilator splitter that may allow paired patients
to be ventilated by one machine [37].
Additive manufacturing has been utilized in the last decade by
the orthopedic implant industry to manufacture implantable
components fundamentally altering the engineering and
manufacturing constraints for these devices [38]. The COVID-19
crisis has increased awareness of the potential to use this
manufacturing technology in orthopedics.
Conclusion
COVID-19 has challenged the health care system in ways that
will reverberate for years to come. The orthopedic community has
risen to the challenge of caring for patients sheltering in place by
exploring and adopting a set of digital health technologies that
have extended the community’s ability to triage and deliver care in
the most appropriate venue, whether that be at home, the clinic, or
the hospital. We believe that many of the technologies presented in
this communication will prove to be useful at simplifying or
addressing pain points that exist in current care models. It can be
argued that the pandemic has afforded us a glimpse into a future
where clinical orthopedics partners with digital health solutions to
create a hybrid: digital orthopedics. As we look forward to the end
of the pandemic, it is likely that we will emerge to find a care de-
livery model that is fundamentally and permanently changed.
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